房天下 > 房天下问答 > 业主生活 > 其他
  • 英语高手过来帮忙翻译!

    请帮忙翻译下面两三段话,翻译的好的话高分献上,另外还会有额外的奖励。 Among the NAFTA proposals are provisions relating to patent protection for pharmaceuticals and provisions relating to regulatory disclosures. NAFTA provides that patents must be available for pharmaceutical and agricultural chemical inventions for which product patents were previously unavailable. Patent protection must be the same in all industrial sectors. This is particularly relevant to Canada, which currently has a different regime for protection of pharmaceutical inventions. NAFTA has served as an impetus to enact Bill C-91 to bring the protection for pharmaceutical inventions in line with that afforded to other technologies. The parties may exclude from patentability plants and animals other than microorganisms and essential biological processes for the production of plants or animals. Patents are to be available without discrimination as to the territory of the party where the invention was made. For U.S. patents, research done in Canada will now be on equal footing with research done in the United States, which is not currently the case. Canadian discrimination against pharmaceutical products not researched and discovered in Canada would be eliminated.

    提问者:笔记本家园

    发布于2010-09-23

共1个回答
  • xingzhanbin 丨Lv 3
    北美自由贸易协定(NAFTA)的提案中,有涉及药品专利保护和调控性披露的条款。北美自由贸易协定规定专利药品和农业化学发明必须有权获得以前无法获得的产品专利。专利保护在所有的行业部门中必须别无二致。这一点尤其与加拿大密切相关,因为加拿大当前对药品发明采取不同的管理体制。北美自由贸易协定一直在充当实施C-91法案的推手,力求使对药品发明的保护与对其它技术的保护不致抵触。各方可能将动植物排除在专利申请之外,只保留微生物以及动植物生产的基本生物过程专利权。 专利的获得将不再有因发明诞生在哪一方国土而产生的歧视。对美国专利而言,在加拿大进行的研究现在将同在美国进行的研究享有同样的地位,而目前情况并非如此。加拿大针对在其国土之外所研发药品的歧视将得以铲除。
    +1 2010-09-23 举报
热门人气推荐
免责声明:问答内容均来源于互联网用户,房天下对其内容不负责任,如有版权或其他问题可以联系房天下进行删除。